UY25792A1 - Preparado farmacéutico de moxifloxacina. - Google Patents

Preparado farmacéutico de moxifloxacina.

Info

Publication number
UY25792A1
UY25792A1 UY25792A UY25792A UY25792A1 UY 25792 A1 UY25792 A1 UY 25792A1 UY 25792 A UY25792 A UY 25792A UY 25792 A UY25792 A UY 25792A UY 25792 A1 UY25792 A1 UY 25792A1
Authority
UY
Uruguay
Prior art keywords
moxifloxacin
pharmaceutical preparation
well
preparation
quinoloncarboxylic
Prior art date
Application number
UY25792A
Other languages
English (en)
Spanish (es)
Inventor
Dr Claus Weisemann
Dr Hans Friedrich Mahler
Dr Patrick Bosche
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY25792(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of UY25792A1 publication Critical patent/UY25792A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
UY25792A 1998-11-10 1999-11-08 Preparado farmacéutico de moxifloxacina. UY25792A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19855758 1998-11-10

Publications (1)

Publication Number Publication Date
UY25792A1 true UY25792A1 (es) 2001-08-27

Family

ID=7889824

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25792A UY25792A1 (es) 1998-11-10 1999-11-08 Preparado farmacéutico de moxifloxacina.

Country Status (41)

Country Link
US (1) US6610327B1 (cg-RX-API-DMAC7.html)
EP (1) EP1128831B1 (cg-RX-API-DMAC7.html)
JP (1) JP4809978B2 (cg-RX-API-DMAC7.html)
KR (1) KR100650489B1 (cg-RX-API-DMAC7.html)
CN (1) CN1149993C (cg-RX-API-DMAC7.html)
AR (1) AR021074A1 (cg-RX-API-DMAC7.html)
AT (1) ATE279193T1 (cg-RX-API-DMAC7.html)
AU (1) AU745282B2 (cg-RX-API-DMAC7.html)
BG (1) BG64974B1 (cg-RX-API-DMAC7.html)
BR (2) BRPI9915208B8 (cg-RX-API-DMAC7.html)
CA (1) CA2349161C (cg-RX-API-DMAC7.html)
CO (1) CO5070571A1 (cg-RX-API-DMAC7.html)
CU (1) CU23260B7 (cg-RX-API-DMAC7.html)
CZ (1) CZ292069B6 (cg-RX-API-DMAC7.html)
DE (1) DE59910858D1 (cg-RX-API-DMAC7.html)
DK (1) DK1128831T3 (cg-RX-API-DMAC7.html)
EE (1) EE04418B1 (cg-RX-API-DMAC7.html)
ES (1) ES2229786T3 (cg-RX-API-DMAC7.html)
HK (1) HK1042245B (cg-RX-API-DMAC7.html)
HN (1) HN1999000183A (cg-RX-API-DMAC7.html)
HR (1) HRP20010332B1 (cg-RX-API-DMAC7.html)
HU (1) HU229065B1 (cg-RX-API-DMAC7.html)
ID (1) ID29089A (cg-RX-API-DMAC7.html)
IL (2) IL142642A0 (cg-RX-API-DMAC7.html)
MA (1) MA26757A1 (cg-RX-API-DMAC7.html)
MY (1) MY121114A (cg-RX-API-DMAC7.html)
NO (1) NO319342B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ511554A (cg-RX-API-DMAC7.html)
PE (1) PE20001304A1 (cg-RX-API-DMAC7.html)
PL (1) PL194020B1 (cg-RX-API-DMAC7.html)
PT (1) PT1128831E (cg-RX-API-DMAC7.html)
RU (1) RU2230555C9 (cg-RX-API-DMAC7.html)
SI (1) SI1128831T1 (cg-RX-API-DMAC7.html)
SK (1) SK283936B6 (cg-RX-API-DMAC7.html)
SV (1) SV1999000194A (cg-RX-API-DMAC7.html)
TR (1) TR200101310T2 (cg-RX-API-DMAC7.html)
TW (1) TW580388B (cg-RX-API-DMAC7.html)
UA (1) UA72483C2 (cg-RX-API-DMAC7.html)
UY (1) UY25792A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000027398A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200103141B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
EP1663226A1 (en) * 2003-09-03 2006-06-07 Ranbaxy Laboratories Limited Pharmaceutical compositions of moxifloxacin and processes for their preparation
CN1330306C (zh) * 2004-08-11 2007-08-08 深圳市天一时科技开发有限公司 莫西沙星明胶胶囊剂及其制备方法
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
CN100363001C (zh) * 2005-09-21 2008-01-23 深圳市天一时科技开发有限公司 一种莫西沙星胶囊剂及其制备方法
PL2349220T3 (pl) * 2008-10-09 2012-12-31 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny
EP2735307A1 (de) 2008-12-08 2014-05-28 Ratiopharm GmbH Kompaktiertes Moxifloxacin
TR200907227A2 (tr) * 2009-09-18 2011-04-21 Bi̇lgi̇ç Mahmut Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) * 2009-11-16 2013-09-11 江苏亚邦强生药业有限公司 莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) * 2010-01-12 2011-07-21 Msn Laboratories Limited Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) * 2010-06-11 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
MX2011004759A (es) 2011-05-04 2012-11-21 Senosiain S A De C V Lab Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) * 2011-10-14 2012-11-20 Закрытое акционерное общество "Брынцалов-А" Фармацевтический препарат моксифлоксацина
WO2013063271A1 (en) * 2011-10-25 2013-05-02 U.S. Phytotherapy, Inc. Artemisinin and berberine compositions and methods of making
EP2770985A4 (en) 2011-10-25 2015-01-21 U S Phytotherapy Inc ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
WO2013081044A1 (ja) * 2011-11-30 2013-06-06 富山化学工業株式会社 1-シクロプロピル-8-(ジフルオロメトキシ)-7-[(1r)-1-メチル-2,3-ジヒドロ-1h-イソインドール-5-イル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸のメタンスルホン酸塩水和物含有錠剤
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) * 2012-02-21 2012-07-04 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) * 2012-04-11 2013-06-05 南京优科生物医药有限公司 一种莫西沙星片剂及其制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) * 2012-10-19 2016-04-20 深圳信立泰药业股份有限公司 一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) * 2013-12-20 2015-06-25 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) * 2014-05-22 2015-08-10 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
WO1989003681A1 (en) * 1987-10-19 1989-05-05 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 6.8−ジフルオロ−1−(2−フルオロエチル)−1,4−ジヒドロ−7−(4−メチル−1−ピペラジニル)−4−オキソ−3−キノリンカルボン酸を有効成分とする錠剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
TW209865B (cg-RX-API-DMAC7.html) * 1992-01-10 1993-07-21 Bayer Ag
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino

Also Published As

Publication number Publication date
AU745282B2 (en) 2002-03-21
CU23260B7 (es) 2008-01-24
RU2230555C2 (ru) 2004-06-20
SV1999000194A (es) 2000-10-16
HN1999000183A (es) 1999-11-01
SI1128831T1 (en) 2005-04-30
ATE279193T1 (de) 2004-10-15
PL194020B1 (pl) 2007-04-30
SK283936B6 (sk) 2004-05-04
BG64974B1 (bg) 2006-11-30
PT1128831E (pt) 2005-01-31
BR9915208A (pt) 2001-07-31
DE59910858D1 (de) 2004-11-18
AU1267400A (en) 2000-05-29
JP4809978B2 (ja) 2011-11-09
HUP0104762A2 (hu) 2002-05-29
HU229065B1 (en) 2013-07-29
WO2000027398A1 (de) 2000-05-18
UA72483C2 (en) 2005-03-15
EE04418B1 (et) 2005-02-15
IL142642A0 (en) 2002-03-10
BRPI9915208B1 (pt) 2011-11-01
HK1042245B (zh) 2005-03-11
BRPI9915208A (pt) 2001-07-31
HUP0104762A3 (en) 2002-10-28
IL142642A (en) 2006-10-05
SK6102001A3 (en) 2001-12-03
ES2229786T3 (es) 2005-04-16
KR20010089424A (ko) 2001-10-06
NO20012248L (no) 2001-06-06
NO319342B1 (no) 2005-07-18
BRPI9915208B8 (pt) 2021-07-06
HRP20010332B1 (hr) 2011-01-31
KR100650489B1 (ko) 2006-11-28
CA2349161A1 (en) 2000-05-18
CZ20011652A3 (cs) 2001-08-15
US6610327B1 (en) 2003-08-26
RU2230555C9 (ru) 2006-02-27
MY121114A (en) 2005-12-30
HK1042245A1 (en) 2002-08-09
ZA200103141B (en) 2002-05-07
JP2002529415A (ja) 2002-09-10
BG105459A (en) 2001-12-29
NO20012248D0 (no) 2001-05-07
PE20001304A1 (es) 2000-12-30
CN1149993C (zh) 2004-05-19
TR200101310T2 (tr) 2001-10-22
HRP20010332A2 (en) 2002-06-30
MA26757A1 (fr) 2004-12-20
AR021074A1 (es) 2002-06-12
CN1325306A (zh) 2001-12-05
EE200100259A (et) 2002-12-16
PL348112A1 (en) 2002-05-06
NZ511554A (en) 2003-07-25
CO5070571A1 (es) 2001-08-28
DK1128831T3 (da) 2005-01-17
EP1128831A1 (de) 2001-09-05
CZ292069B6 (cs) 2003-07-16
ID29089A (id) 2001-07-26
TW580388B (en) 2004-03-21
CA2349161C (en) 2008-01-29
EP1128831B1 (de) 2004-10-13

Similar Documents

Publication Publication Date Title
SV1999000194A (es) Preparado farmaceuticio de moxifloxacina ref. lea 33327-sv
MY117492A (en) New crystal modification of cdch, a process for its preparation and pharmaceutical formulations comprising this modification
NZ227680A (en) Quinoline and naphthyridine derivatives, intermediates and pharmaceutical compositions
HU9403112D0 (en) Process for producing quinolin-4-amine-and 1h-imidazo[4,5-c]quinolin-4-amine derivatives as intermediates
ATE169299T1 (de) Antivirale 2-ethyl-1h-imidazo(4,5-c)chinolin-4- amine
BG103969A (en) C-4"-substituted macrolide derivatives
BR0114584A (pt) Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento
SG127738A1 (en) Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds
YU29502A (sh) Proces dobijanja 4"-supstituisanog 9-dezokso-9a-aza-9a derivata homoeritromicina a
BG103474A (en) Application of derivatives of 7-(2-oxa-5,8-diazobicyclo[4,3,0]non-8-8-yl)-quinoloncarboxylic acid and naphthyridoncarboxylic acid in the therapy of helicobacter pylor infections and the gastroduodenal diseases related to them
UY26269A1 (es) Formulación de sal común y moxifloxacina
BR0014981A (pt) Derivados de naftiridina
BR9808290A (pt) Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação
CA2351429A1 (en) 13-membered azalides and their use as antibiotic agents
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
PT85411A (en) 7-]]3-(aminomethyl)-3-alkyl"-1-pyrrolidinyl"-quinoline-carboxylic acids
MY129437A (en) Drug formulation having controlled release of active compound
AR002753A1 (es) El acido 7-([1 alfa,5 alfa,6 alfa]-6-amino-3-azabiciclo[3.1.0]hex-3-il)-6- fluor-1-(2,4-difluorofenil)-1,4-didhiro-4-oxo-1,8-naftiridin-3-carboxilico, saldel acido metanosulfonico, un procedimiento para prepararla y una composicion farmaceutica con actividad bacteriana que la comprende
EE200100377A (et) Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
HUP0002963A3 (en) Use of pyrazolo-[4,3-d] pyrimidinon derivatives for the production of pharmaceutical compositions for treating diseases of the eye field
AU569532B2 (en) Pyrazolo(3,4,5- kl) acridines
IL94701A0 (en) Crystalline cephem acid addition salts and processes for their preparation
CO4930262A1 (es) Producto farmaceutico cristalino, su preparacion y uso como sustancia terapeutica
CA2217417A1 (en) 9-n-ethenyl derivatives of 9(s)-erythromycylamine
ECSP993210A (es) Preparado farmaceutico de moxifloxacina (lea 33327-ec)

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20160810